At the time of writing, Can-Fite Biopharma Ltd ADR [CANF] stock is trading at $0.53, up 7.76%. An important factor to consider is whether the stock is rising or falling in short-term value. The CANF shares have lost -10.68% over the last week, with a monthly amount drifted -18.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Can-Fite Biopharma Ltd ADR [AMEX: CANF] stock has seen the most recent analyst activity on August 11, 2017, when Maxim Group initiated its Buy rating and assigned the stock a price target of $7. H.C. Wainwright reiterated its Buy rating and increased its price target to $6 on November 30, 2015. H.C. Wainwright reiterated its recommendation of a Buy and reduced its price target to $3 on March 31, 2015. ROTH Capital downgraded its rating to Neutral for this stock on March 30, 2015, and downed its price target to $2.40. In a note dated December 29, 2014, ROTH Capital reiterated a Buy rating on this stock and revised its target price from $28 to $20.
For the past year, the stock price of Can-Fite Biopharma Ltd ADR fluctuated between $0.47 and $3.12. Currently, Wall Street analysts expect the stock to reach $7.25 within the next 12 months. Can-Fite Biopharma Ltd ADR [AMEX: CANF] shares were valued at $0.53 at the most recent close of the market. An investor can expect a potential return of 1267.92% based on the average CANF price forecast.
Analyzing the CANF fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -15.95%, Pretax Profit Margin comes in at -15.71%, and Net Profit Margin reading is -15.71%. To continue investigating profitability, this company’s Return on Assets is posted at -1.14, Equity is -1.83 and Total Capital is -1.6. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Can-Fite Biopharma Ltd ADR [AMEX:CANF] has a current ratio of 3.60. On the other hand, the Quick Ratio is 3.60, and the Cash Ratio is 3.04.
